Home > Boards > US OTC > Biotechs > Inhibitor Therapeutics Inc. (INTI)

Hi Rosym, it's nice to see another (presumably)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
jdno Member Profile
 
Followed By 3
Posts 73
Boards Moderated 0
Alias Born 08/19/13
160x600 placeholder
jdno   Tuesday, 07/18/17 09:28:16 AM
Re: None
Post # of 388 
Hi Rosym, it's nice to see another (presumably) real-life shareholder of HPPI on this board.

Anyhow, this is a few weeks old by now, but I came across this insider filing recently. It looks like Frank O'Donnell, the principal of Hedgepath LLC, which is one of his private equity firms and one of the principal founding firms of HPPI (along with Mayne Pharma), sold 2.5M shares of HPPI for $0.20/share at the end of June in a private transaction. Very curious action there imo given the stock had been trading at $0.30-$0.35/share for quite a while. Frank is quite wealthy, so I'm quite sure the $500k this transaction netted him isn't critical to his personal life. It must be strategic in nature somehow, in the sense that an institution wanted to invest in HPPI but didn't want to have to buy in the open market, where the stock has very, very limited liquidity. I wish there was a way to find out who bought these shares from him, perhaps in time in a future filing it will be disclosed, but I'm not sure about that. It's also strange that this filing isn't on the SEC's EDGAR site yet.

http://insideri.com/1584617_000089924317018211_0000899243-17-018211



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist